76679-47-5

Basic information

• Product Name: methyl-2,3,4-tri-O-benzyl-6-O-trifluoromethanesulfonyl-α-D-glucopyranoside
• Synonyms: methyl-2,3,4-tri-O-benzyl-6-O-trifluoromethanesulfonyl-α-D-glucopyranoside
• CAS NO: 76679-47-5
• Molecular Weight: 596.622
• Mol File: 76679-47-5.mol

Chemical Properties

• CAS DataBase Reference: methyl-2,3,4-tri-O-benzyl-6-O-trifluoromethanesulfonyl-α-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl-2,3,4-tri-O-benzyl-6-O-trifluoromethanesulfonyl-α-D-glucopyranoside(76679-47-5)
• EPA Substance Registry System: methyl-2,3,4-tri-O-benzyl-6-O-trifluoromethanesulfonyl-α-D-glucopyranoside(76679-47-5)

Safety Data

• Hazardous Substances Data: 76679-47-5(Hazardous Substances Data)

Upstream product

• 100-39-0 benzyl bromide 
• 7177-79-9 methyl 2,3-O-dibenzyl-4,6-O-benzylidene-α-D-glucopyranoside 
• 3162-96-7 4,6-O-benzylidene-1-O-methyl-α-D-glucopyranoside 
• 53008-65-4 methyl 2,3,4-tri-O-benzyl-D-glucopyranoside 

Downstream Products

• 136824-11-8 methyl 3,4,6-tri-O-benzyl-β-D-mannopyranosyl-(1->6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 1561048-86-9 C₄₂H₅₀O₁₀ 
• 104976-41-2 Methyl-2,3,4-tri-O-benzyl-6-O-<1D-(1,2,4/3)-2,3,4-tri-O-benzyl-1,2,3,4-tetrahydroxy-5-C-hydroxymethyl-5-cyclohexen-1-yl>-α-D-glucopyranosid 
• 104976-43-4 (2S,3R,4S,5S,6R)-2-Methoxy-6-((1S,2R,3S,4R,5R)-2,3,4-trihydroxy-5-methyl-cyclohexyloxymethyl)-tetrahydro-pyran-3,4,5-triol 

Relevant articles and documents

Substrate Substitution in Kanosamine Biosynthesis Using Phosphonates and Phosphite Rescue

Kanosamine is an antibiotic and antifungal compound synthesized from glucose 6-phosphate (G6P) inBacillus subtilisby the action of three enzymes: NtdC, which catalyzes NAD-dependent oxidation of the C3-hydroxyl; NtdA, a PLP-dependent aminotransferase; and

α-glucosidase inhibitors

This invention relates to novel polyglycosidyl derivatives of 1-deoxy-nojirimycin, to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes.

α-glucosidase inhibitors

This invention relates to novel N-glycosyl derivatives of 1,4-dideoxy-1,4-imino-D-arabinitol, to the chemical processes for their preparation, to their α-glucosidase inhibiting properties, and to their end-use application in the treatment of diabetes, obe

Novel alpha-glucosidase inhibitors

This invention relates to novel N-derivatives, of 1,4-di--deoxy-1,4-imino-L-arabinitol (I), to the processes for their preparation and to their end-use applications, particularly as to their use in the treatment of diabetes. wherein n is zero, one or two,